GlaxoSmithKline Sues Moderna for Patent Infringement Over COVID Vaccines
Insurance Journal - Oct 15, 2024
British drugmaker GlaxoSmithKline sued Moderna in federal court in Delaware on Tuesday, accusing its American rival of violating GSK’s patent rights in messenger RNA (mRNA) technology with its blockbuster COVID-19 vaccine Spikevax. According to the two lawsuits, Moderna’s lipid nanoparti...
Recommended Articles
Posted: Jul 02, 2025
Washington Insurance Commissioner Patty Kuderer convened her first Artificial Intelligence Advisory...
Posted: Jul 02, 2025
Law enforcement officials are investigating a former employee of a company that negotiates with hack...
Posted: Jul 02, 2025
The era of massive state budget surpluses in Texas could be coming to an end. As the last of the fed...